2/13/2023 | EULM | GlaxoSmithKline repurchases sterling-denominated notes due 2033, 2039
|
11/15/2022 | EULM | GlaxoSmithKline accepts £1.59 billion tendered notes from four series
|
11/8/2022 | EULM | GlaxoSmithKline launches capped tender offer for five sterling notes
|
4/14/2022 | IGLM | GlaxoSmithKline elects to redeem 2.875% notes due 2022 on May 1
|
9/28/2020 | EMHYPFPV | Market Commentary: GlaxoSmithKline, Toyota, PPL, Entergy, Edison price; investment-grade credit spreads firm
|
9/28/2020 | IG | Market Commentary: GlaxoSmithKline, Toyota, PPL, Entergy, Edison price; investment-grade credit spreads firm
|
9/28/2020 | IG | New Issue: GlaxoSmithKline prices $1.25 billion of 0.534% three-year notes at 38 bps spread
|
9/28/2020 | IG | Market Commentary: Morning Commentary: GlaxoSmithKline, PPL, Entergy, Edison, National Rural offer bonds
|
9/28/2020 | IG | GlaxoSmithKline intends to price notes due 2023 via four bookrunners
|
5/28/2019 | IG | Fitch lowers GlaxoSmithKline
|
3/19/2019 | EMHYPFPV | Market Commentary: Royal Bank of Scotland, Ingersoll-Rand, Nutrien, Essex price; Florida Power in pipeline
|
3/19/2019 | IG | Market Commentary: Royal Bank of Scotland, Ingersoll-Rand, Nutrien, Essex price notes; Florida Power in pipeline
|
3/19/2019 | IG | Market Commentary: Morning Commentary: Ingersoll-Rand, Royal Bank of Scotland, Nutrien, Essex on deck
|
3/19/2019 | IG | New Issue: GlaxoSmithKline Capital details $3.5 billion three-part sale of guaranteed notes
|
3/18/2019 | EMHYPFPV | Market Commentary: GlaxoSmithKline sells $3.5 billion notes; Target, SEB, utilities tap high-grade market
|
3/18/2019 | IG | Market Commentary: GlaxoSmithKline sells $3.5 billion notes; Target, SEB, utilities tap high-grade market
|
3/18/2019 | IG | New Issue: GlaxoSmithKline sells $3.5 billion of guaranteed notes in three parts
|
3/18/2019 | IG | Market Commentary: Morning Commentary: GlaxoSmithKline, Target, utilities to tap high-grade bond market
|
3/18/2019 | IG | GlaxoSmithKline Capital to price fixed- and floating-rate guaranteed notes in four tranches
|
5/5/2017 | SP | New Issue: Barclays sells $1.9 million phoenix autocallable notes on two stocks
|
5/27/2016 | IG | Fitch lowers GlaxoSmithKline
|
12/17/2014 | IG | Fitch lowers GlaxoSmithKline view to negative
|